残余胆固醇与2型糖尿病合并新发糖尿病肾病患者心血管死亡的关系
本研究纳入2282例2型糖尿病、慢性肾脏病3-5期且新诊断糖尿病肾病的成人,基线血脂并随访2年内心血管死亡。多变量校正分析显示,残余胆固醇每升高10 mg/dL,心血管死亡风险增加(OR 1.115,95%CI 1.103-1.127),且残余胆固醇≥30 mg/dL与LDL-C>100 mg/dL交互时风险最高(OR 1.696,95%CI 1.613-1.783)。
要点
- 残余胆固醇升高与2型糖尿病合并CKD 3-5期及新发糖尿病肾病患者心血管死亡风险独立相关。
- 残余胆固醇≥30 mg/dL可区分心血管死亡高风险患者。
- 残余胆固醇与LDL-C同时升高时心血管死亡风险最高。
核心结论
- 在2型糖尿病、CKD 3-5期且新发糖尿病肾病患者中,残余胆固醇与心血管死亡风险升高相关。
- 与一般人群不同,残余胆固醇与LDL-C的交互作用与最高心血管死亡风险相关。
研究设计与样本
- 研究纳入2282例成人,基线时间为2015年1月1日至2016年12月31日。
- 研究对象为2型糖尿病、CKD 3-5期且新诊断糖尿病肾病患者。
- 研究测定基线血脂谱并随访2年内心血管死亡,采用校正逻辑回归模型分析。
主要发现
- 多变量校正分析中,LDL-C每10 mg/dL的OR为1.022(95%CI 1.017-1.026)。
- HDL-C每5 mg/dL的OR为0.929(95%CI 0.922-0.936)。
- 非HDL-C每10 mg/dL的OR为1.024(95%CI 1.021-1.028)。
- 残余胆固醇每10 mg/dL的OR为1.115(95%CI 1.103-1.127)。
- 动脉粥样硬化性血脂异常(甘油三酯>150 mg/dL且男性HDL-C<40 mg/dL或女性<50 mg/dL)的OR为1.073(95%CI 1.031-1.116)。
关键数值与推荐
- 残余胆固醇≥30 mg/dL可区分心血管死亡高风险患者。
- 残余胆固醇与LDL-C>100 mg/dL交互时风险最高,OR为1.696(95%CI 1.613-1.783)。
临床怎么用
- 对2型糖尿病合并CKD 3-5期及新发糖尿病肾病患者,应关注残余胆固醇水平以评估心血管死亡风险。
- 残余胆固醇与LDL-C同时升高提示心血管死亡风险最高,需加强风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The association between remnant cholesterol (remnant-C) and cardiovascular mortality in patients with type 2 diabetes (T2D) and incident diabetic nephropathy remains unclear. OBJECTIVE: To examinie the association between remnant-C and cardiovascular mortality in patients with T2D, chronic kidney disease (CKD) stages 3 to 5, and newly diagnosed DN. METHODS: This study determined the baseline lipid profile and searched for deaths with cardiovascular disease (CVD) within 2 years of baseline among 2282 adults enrolled between January 1, 2015 and December 31, 2016, who had T2D, CKD stages 3 to 5, and newly diagnosed DN. Adjusted logistic regression models were used to assess the associations between lipid, especially remnant-C concentration (either as continuous or categorical variables), and risk of cardiovascular mortality. RESULTS: In multivariable-adjusted analyses, low-density lipoprotein cholesterol (LDL-C) (odds ratio [OR], 1.022; 95% CI, 1.017-1.026, per 10 mg/dL), high-density lipoprotein cholesterol (HDL-C) (OR, 0.929; 95% CI, 0.922-0.936, per 5 mg/dL), non-HDL-C (OR, 1.024; 95% CI, 1.021-1.028, per 10 mg/dL), and remnant-C (OR, 1.115; 95% CI, 1.103-1.127, per 10 mg/dL), but not triglycerides were associated with cardiovascular mortality. Atherogenic dyslipidemia (triglycerides > 150 mg/dL [1.69 mmol/L] and HDL-C < 40 mg/dL in men or < 50 mg/dL in women) was also associated with cardiovascular mortality (OR, 1.073; 95% CI, 1.031-1.116). Remnant-C greater than or equal to 30 mg/dL differentiated patients at a higher risk of cardiovascular mortality from those with lower concentrations, especially with interaction with LDL-C level greater than 100 mg/dL: The highest risk was found in patients with higher levels both of remnant-C and LDL-C (OR, 1.696; 95% CI, 1.613-1.783). CONCLUSION: In patients with T2D, CKD stages 3 to 5, and incident DN, remnant-C was associated with a higher risk of death with CVD. Different from the general population, the interaction of remnant-C and LDL-C was associated with the highest risk of cardiovascular mortality.
引用
- Yu D, Wang Z, Zhang X, et al. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy. J Clin Endocrinol Metab. 2021. PMID: 34291804. doi:10.1210/clinem/dgab533
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。